Taken together, our findings provide insight into the molecular mechanism modulating breast cancer cell anoikis and metastasis and offer the probable therapeutic value of the HBXIP/Nrf2 axis in breast cancer patients. The gene discussed is LAMTOR5; the disease is breast carcinoma.